Immunological signature of patients with thymic epithelial tumors and Good syndromeAnna Maria Malfitano, Pietro Formisano, Mario Giuliano et al.|Frontiers in Immunology|2022Cited by 16
Multidisciplinary approach for rare thoracic tumors during COVID-19 pandemicErica Pietroluongo, Mario Giuliano, Pietro De Placido et al.|Mediastinum|2022Cited by 10
The unusual first sign of presentation of renal cell carcinoma: a rare case reportRocco Morra, Mario Giuliano, Antonio D’Ambrosio et al.|AME Case Reports|2022Cited by 3
Results of TETimaX Trial of Langerhans Cell Histiocytosis Treatment and Perspectives on the Role of Imatinib Mesylate in the Era of MAPK SignalingLiliana Montella, Giovannella Palmieri, Gaetano Facchini et al.|Biomedicines|2021Cited by 2
The European Reference Network: the keystone for the management of rare thoracic cancersRocco Morra, Mario Giuliano, Antonio D’Ambrosio et al.|Mediastinum|2022Cited by 2